ISLB 2025

A meeting endorsed by the ISLB is an event where the overall educational program has been reviewed by the ISLB and the meeting represents a multidisciplinary educational approach which meets minimum applicable criteria set by our society. However, the ISLB is not a planner and does not control the content, logistics, or any financial aspects related to endorsed meetings.

Events name: The “Focus on TOP” symposium
Date: 17-18 March 2025

The “Focus on TOP” symposium (Udine, March 17-18, 2025) is designed to address the rapidly evolving landscape of breast cancer management, which has shifted toward a personalized treatment paradigm. With advances in targeted therapies and biomarker development—ranging from circulating tumor cells to circulating tumor DNA, next-generation sequencing, and multi-omics—the field demands collaborative, interdisciplinary solutions to harness these complex tools for clinical impact.

Events name: European Association for Cancer Research (EACR 2025)
Date: 16 – 19 June 2025

The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025) is a four-day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations. Join us in Lisbon, Portugal between 16 and 19 June 2025 to hear from world-renowned researchers and up-and-coming scientists, as well as key industry actors and big names in scientific publishing. Abstract submission and registrations are both now open; visit the website to read more.

In this video, Prof. Frédérique Penault-Llorca and Dr Aditya Bardia explore the evolving landscape of biomarker testing in HR+/HER2- metastatic breast cancer. The experts discuss when and how to effectively utilise liquid and tumour biopsies, the importance of including all relevant biomarkers in test requests throughout the patient journey, and how these test results directly impact treatment decisions and patient management. This discussion offers valuable guidance for optimising personalised care in advanced breast cancer. Watch the video and download the accompanying slides for more details.

Events name: 20th Anniversary Circulating Tumor Cells
Date: 05/24/2024 – 05/25/2024

Unveiling the impact of circulating tomor cells: Two decades of discovery and clinical advancements in solid tumors.